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Abstract
The difference in restricted mean survival times between two groups
is a clinically relevant summary measure. With observational data,
there may be imbalances in confounding variables between the two
groups. One approach to account for such imbalances is to esti-
mate a covariate-adjusted restricted mean difference by modeling the
covariate-adjusted survival distribution and then marginalizing over
the covariate distribution. We demonstrate that the mean-squared er-
ror of the restricted mean difference is bounded by the mean-squared
error of the covariate-adjusted survival distribution estimators. This
implies that a better estimator of the covariate-adjusted survival dis-
tributions is associated with a better estimator of the restricted mean
difference. Thus, this paper proposes estimating restricted mean dif-
ferences with stacked survival models. Stacked survival models es-
timate a weighted average of several survival models by minimiz-
ing predicted error. By including a range of parametric and semi-
parametric models, stacked survival models can effectively estimate a
covariate-adjusted survival distribution and, therefore, the restricted
mean treatment effect in a wide range of scenarios. We demonstrate
through a simulation study that the new estimator can perform nearly
as well as Cox regression when the proportional hazards assumption
is satisfied and significantly better when proportional hazards is vio-
lated. The proposed estimator is also illustrated with data from the
United Network for Organ Sharing to evaluate post-lung transplant
survival between large and small-volume centers.
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1 Introduction
Patients with end-stage lung disease (e.g., advanced cystic fibrosis) may be
eligible for lung transplantation after other treatment options fail. Unfortu-
nately, post-transplant survival is poor after lung transplantation, especially
in comparison to other solid organ transplants, with one and three-year graft
survival of 79% and 64%, respectively. Given the poor prognosis, understand-
ing the factors related to post-transplant survival remains an important but
controversial task. For example, previous research has suggested that trans-
plant center volume (which we operationalize as the number of lung trans-
plants performed at a center over the preceding two years) is associated with
post-transplant survival with higher volume centers associated with lower
mortality (Weiss et al., 2009; Thabut et al., 2010). However, the effect of
center volume after properly adjusting for confounders remains unclear.
In the absence of censoring, the difference in post-transplant survival time
between high and low volume centers would be traditionally summarized by
the difference in mean survival time. However, the mean for a non-negative
random variable (e.g., survival time) is defined as E{T} = ∫∞
0
S(t)dt, where
S(t) = P (T > t) is the survival function of the random variable T . The
estimate of the mean is, therefore, not defined when Sˆ(t) > 0 for all observed
t, a situation regularly experienced with even light censoring. Furthermore,
there exists no consistent estimator of E{T} when S(tmax), where tmax is the
maximum follow-up time. Since substantial censoring is experienced in lung
transplantation, a different summary measure is required.
The restricted mean is an alternative summary measure that is always
estimable in the presence of right-censored survival times (Royston and Par-
mar, 2013). The τ -restricted mean truncates observations at some time point
τ [i.e., E{min(T, τ)} = ∫ τ
0
S(t)dt]. By choosing a value for τ within the ob-
served follow-up time, the restricted mean is an estimable summary measure
with a direct interpretation that is closely related to the mean. For exam-
ple, the average difference in post-transplant survival over one year between
high-volume and low-volume centers is the difference in one-year restricted
means between the two groups. However, estimating the difference of the
restricted mean survival time with data from observational studies, such as
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the data available in the lung transplantation example, is difficult due to
potential confounding. In particular, the difference in the area under the
Kaplan-Meier survival curve up to time τ is not necessarily a consistent es-
timator of the causal restricted mean difference between the two treatment
groups.
To account for imbalances in confounders between the two treatments,
several researchers have proposed estimating the covariate-adjusted restricted
mean difference by modeling the covariate-adjusted survival distribution (i.e.,
estimating the conditional survival function), and then marginalizing over
the covariate distribution to estimate restricted mean difference (referred
to as the “regression” approach). For such an approach, the model of the
covariate-adjusted survival distribution (or the estimator of the conditional
survival function) defines the estimator of the restricted mean difference.
The covariate-adjusted survival distribution is often assumed to follow a
proportional hazards model. For example, Karrison (1987) proposed mod-
eling the survival time distribution as a proportional hazards model with a
piecewise constant baseline hazard function. As a natural alternative, Zucker
(1998) proposed a proportional hazards model with an unspecified baseline
hazard, i.e., a Cox proportional hazards model (Cox, 1972). Both Karri-
son and Zucker assume that the proportional effect of the covariates on the
hazard is the same for each treatment. Chen and Tsiatis (2001) relax this
assumption by estimating separate baseline hazard functions and covariate
effects for each treatment.
Unfortunately, the proportional hazards assumption may not hold in
many applications. For example, centers with greater lung transplant volume
are more likely to perform bilateral lung transplants (as opposed to single
lung transplants), and the type of lung transplant is well-known to violate
the proportional hazards assumption (Thabut et al., 2009). As such, cur-
rent approaches, which rely on the proportional hazards assumption, may
produce biased and inefficient estimates of the restricted mean difference
between high volume and low volume centers. As an alternative, we could
estimate the survival distribution with a different model (e.g., an accelerated
failure time model), but the estimator would then be biased if the acceler-
ated failure time assumption is violated. Rather than rely on a particular
parametric or semi-parametric model, we pursue a flexible estimator of the
conditional survival function and, therefore, of the restricted mean difference
that performs well across a wide range of situations.
In particular, we investigate ‘stacked survival models’ for estimating the
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conditional survival function. Stacking finds a weighted average of several
conditional survival function estimators by minimizing predicted error (Wey
et al., 2013). Since the minimization is based on predicted error, stacking
can include parametric models, semi-parametric models and non-parametric
models. This allows more weight to be given to the model that most accu-
rately estimates the underlying survival function for a given situation and
sample size. Wey et al. (2013) demonstrated that the stacked survival model
is competitive with parametric models and the Cox proportional hazards
model for estimating the conditional survival function when assumptions are
satisfied, but performs better when assumptions are violated. We show that
the mean-squared error of the restricted mean difference estimator is bounded
by the mean-squared error of estimator the conditional survival function. As
such, better estimators of the conditional survival function will generally
lead to a better estimator of the restricted mean difference. Therefore, our
goal is the improvement of restricted mean treatment effect estimation in a
wide range of situations by estimating the conditional survival function with
stacked survival models.
Section 2 introduces the estimator of the restricted mean treatment effect
and bounds the mean-squared error (MSE) of the restricted mean treatment
effect by the mean-squared error of the conditional survival function. Sec-
tion 3 outlines how stacked survival models can be applied to restricted mean
treatment effect estimation. A simulation study evaluates the finite sample
performance of the proposed estimator in Section 4. The proposed estimator
is then applied to a observational registry of post-lung transplantation sur-
vival from the United Network for Organ Sharing in Section 5. Concluding
remarks are presented in Section 6.
2 Proposed Estimator
Throughout the paper, random variables and observed variables are dis-
tinguished by capital and lower case letters, respectively. The factor (i.e.,
the treatment or condition), which the restricted mean survival is compared
across, is denoted by ai, where i denotes the subject, and follows the Bernoulli
random variable A (i.e., A = {0, 1}). Additional covariates, denoted by vec-
tor xi, are measured at the beginning of the study and follow the distribution
of the random variableX. For this paper, we define the non-negative survival
time random variable as T = T 0 · I(A = 0) +T 1 · I(A = 1), where T 0 and T 1
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are the (possibly unobservable) survival time random variables had a patient
received treatment 0 and 1, respectively. We assume that there are no un-
measured confounders; that is, the set of potential outcomes, (T 0, T 1), is con-
ditionally independent of A given X (i.e., (T 0, T 1)⊥ A |X, where ⊥ denotes
statistical independence). The censoring time is ci, which follows the distri-
bution of the continuous non-negative random variable C and is assumed
to be conditionally independent of (T 0, T 1) (i.e., (T 0, T 1) ⊥ C | {X, A}).
Hence a sample of right censored survival data for n patients is {yi, δi, ai,xi},
i = 1, ..., n, where yi = min(ti, ci) and δi = I(ti < ci).
Now let S(A=a)(t|X = x) = P (T > t|X = x, A = a) and G(A=a)(t|X =
x) = P (C > t|X = x, A = a) be, respectively, the treatment-specific con-
ditional survival functions for the covariate-adjusted survival and censor-
ing distributions for treatment a. For brevity, we write throughout that
S(A=a)(t|X = x) = S(a)(t|x) and G(A=a)(t|X = x) = G(a)(t|x).
2.1 Restricted Mean Treatment Effects
Following the outline of Chen and Tsiatis (2001), we estimate the restricted
mean for each treatment group with the “regression” approach, which in-
volves modeling the covariate-adjusted survival time distribution. In partic-
ular, the restricted mean for treatment a is defined as
µ(τ, a) ≡ E{min(T a, τ)} = EX [E{min(T a, τ)|X = x}]
= EX [E{min(T, τ)|X = x, A = a}] (1)
= EX
{∫ τ
0
S(a)(t|x)dt
}
,
where (1) holds due to the assumption that (T 0, T 1)⊥A|X (i.e., the assump-
tion of no unmeasured confounders). It is important to note that the outer
expectation in (1) is taken with respect to the marginal, rather than condi-
tional, covariate distribution.
Once we estimate the treatment-specific conditional survival functions,
S(a)(t|x), then we estimate the expectation over the covariate space with
the empirical covariate distribution. Thus, the estimator for the τ -restricted
mean of the potential outcome T a is
µˆ(τ, a) =
1
n
n∑
i=1
∫ τ
0
Sˆ(a)(t|xi)dt, (2)
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where Sˆ(a)(t|xi) is the estimate of S(a)(t|xi). In practice, a closed form solu-
tion of equation (2) may not exist, and we, therefore, approximate equation
(2) by
µˆ(τ, a) ≈ 1
n
n∑
i=1
Nτ∑
j=1
(t(j) − t(j−1))× Sˆ(a)(t(j−1)|xi), (3)
where t(j) are the ordered event times, i.e., t(j) − t(j−1) ≥ 0 for all j = 1..., n,
and Nτ is one more than the number of event times less than τ . If no event
time equals τ (i.e., t(j) 6= τ for all j = 1, ..., n), then t(Nτ ) = τ and t(Nτ−1)
is the largest event time less than τ . For two treatments, the estimated
difference in restricted mean survival time is
γˆ(τ) = µˆ(τ, a = 1)− µˆ(τ, a = 0), (4)
which also corresponds to the difference in the area under the estimated
survival curves for the two potential outcomes up to time τ .
2.2 Influence of Treatment-Specific Conditional Sur-
vival Functions
There is a clear connection between the restricted mean treatment effect and
the treatment-specific conditional survival functions. We further formalize
this connection by placing an upper bound on the MSE of the restricted
mean treatment effect estimator that depends on the MSE of the estimators
for the treatment-specific conditional survival functions.
Theorem 1. Define the mean-squared error of a restricted mean treatment
effect estimator as MSE[γˆ(τ)] = E[γˆ(τ)− γ(τ)]2, then
MSE[γˆ(τ)] ≤ τ ×
[
MSEτ{Sˆ(0)(·|x)}+ MSEτ{Sˆ(1)(·|x)}
]
,
where MSEτ{Sˆ(a)(·|x)} = E
∫ τ
0
[Sˆ(a)(t|x)− S(a)(t|x)]2dt is the mean-squared
error of an estimator of the treatment-specific conditional survival function
for treatment a. Note that the expectation is over the random variable for
the covariate space and the sampling distribution of the conditional survival
function estimator.
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The inequality (see the Supporting Information for the proof) illustrates
that the MSE of the restricted mean treatment effect should be associated
with the MSE of the treatment-specific conditional survival functions. Of
course, mean-squared error decomposes into a squared bias term and a vari-
ance term, which implies the following corollary
Corollary 2. Define Bias[γˆ(τ)] = E{γˆ(τ)−γ(τ)} and Var[γˆ(τ)] = E{γˆ(τ)−
Eγˆ(τ)}2 as, respectively, the bias and variance of the restricted mean treat-
ment effect, then
Bias[γˆ(τ)]2 ≤ τ ×
[
MSEτ{Sˆ(0)(·|x)}+ MSEτ{Sˆ(1)(·|x)}
]
− Var[γˆ(τ)]
< τ ×
[
MSEτ{Sˆ(0)(·|x)}+ MSEτ{Sˆ(1)(·|x)}
]
,
since Var[γˆ(τ)] > 0.
Thus, the performance of the treatment-specific conditional survival func-
tions places an upper bound on both traditional measures of performance
(i.e., bias and MSE) for the restricted mean treatment effect. The bound on
the squared bias, or absolute bias, is less tight than the bound on the MSE
due to a positive, and potentially large, variance term. Therefore, we would
expect a relatively strong association between the MSE of the restricted
mean treatment effect and the MSE of the treatment-specific conditional
survival functions, but a relatively weak association between the bias of the
restricted mean treatment effect and the MSE of the treatment-specific con-
ditional survival functions. The simulation study in Section 4 presents an
empirical demonstration of this relationship.
3 Stacked Survival Models
Since the performance of the restricted mean treatment effect estimator is
closely related to the performance of the treatment-specific conditional sur-
vival function estimator, we propose estimating restricted mean treatment
effects with stacked survival models. Stacked survival models estimate a
weighted combination of survival models that can span parametric, semi-
parametric, and non-parametric models by minimizing prediction error. For
estimating conditional survival functions, non-parametric estimators can be
preferred to parametric and semi-parametric estimators due to relaxed as-
sumptions. Yet, even when misspecified, parametric and semi-parametric
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estimators can possess better operating characteristics in small sample sizes
due to smaller variance than non-parametric estimators. Fundamentally, this
is a bias-variance tradeoff situation and, by minimizing predicted error, stack-
ing estimates an optimal combination of survival models that balances the
bias-variance trade-off of each estimator at a given sample size. In particular,
Wey et al. (2013) illustrate that stacked survival models effectively estimate
a conditional survival function across a wide range of situations.
In uncensored settings, stacking estimates the optimal weighted average
of several candidate models by minimizing predicted squared error (Breiman,
1996). However, predicted squared error is often poorly defined in censored
settings due to potentially unobserved event times. Therefore, a different
loss function that is tailored to censored data is required. Wey et al. (2013)
evaluate the Brier Score (Graf et al., 1999) over a grid of time points for stack-
ing survival models. In addition, they show that, under certain conditions,
the stacked survival model using the Brier Score is uniformly consistent for
the true conditional survival function. This section focuses on appropriately
modifying stacked survival models for estimating restricted means.
The Brier Score (Graf et al., 1999) measures the predicted squared error of
a conditional survival function at a particular time point. Following Lostritto
et al. (2012), the estimated Brier Score for a given estimator of the conditional
survival function for treatment a at a single time point t can be written as
B̂S
(a)
(t) =
1
n
∑
iΓa
∆i(t)
Gˆ(a)(min{ti, t}|xi)
× {Zi(t)− Sˆ(a)(t|xi)}2, (5)
where Zi(t) = I(ti > t), ∆i(t) = I(min{ti, t} ≤ ci), Gˆ(a)(·|xi) is the estimated
conditional survival function of the censoring distribution for subjects that
received the ath treatment, and Γa is the set of patients that received treat-
ment a. For a fixed time t, censored observations with ci > t will contribute
to the Brier Score, but when ci < t the censored observations will only con-
tribute to the Brier Score indirectly through the estimation of G(a)(Ti(t)|xi).
In this paper, Gˆ(a)(·|xi) is the (unconditional) treatment-specific Kaplan-
Meier survival estimator denoted here after as Gˆ(a)(·).
To estimate the conditional survival function for each treatment group,
the stacking procedure considers the same set of m candidate models, and
each model has a corresponding conditional survival function estimate, say
Sˆ
(a)
k (t|x) for k = 1, ...,m survival models. The set of candidate survival
models included in the stack has an influence on the performance of the
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stacked estimator. In particular, Breiman (1996) and Wey et al. (2013) found
that stacking performs well with a diverse set of models. We note, however,
that other combinations of survival models could be included in the stack.
Since the goal is estimating the entire conditional survival function up to time
τ , stacked survival models minimize the sum of B̂S
(a)
(t) over a set of time
points, say {t1, ..., ts}. The stacking weights for the m models are estimated
by a weighted least squares problem with the additional constraints that
αˆ
(a)
k ≥ 0 for k = 1, ...,m and
∑m
k=1 αˆ
(a)
k = 1:
αˆ(a) = arg min
α(a),α
(a)
k ≥0
s∑
r=1
∑
iΓa
∆i(tr)
Gˆ(a)(min{ti, tr})
× {Zi(tr)−
m∑
k=1
αkSˆ
(a,−i)
k (tr|xi)}2,(6)
where Sˆ
(a,−i)
k (t|xi) is the survival estimate from the kth model while leaving
the ith observation out during the fitting process. This ensures that stacking
does not reward models that over-fit the data. This is traditionally done
by leaving only the ith observation out in the fitting process. However, the
computational requirements induced by bootstrapping for confidence inter-
val estimation (which is discussed subsequently) prevent fitting the set of
candidate survival models n separate times. The data are instead randomly
split into five equally sized sets and Sˆ
(a,−i)
k (t|xi) is obtained for observations
in a given set by fitting the survival models to the observations in the other
four sets. As such, five sets of survival models, rather than n sets of survival
models, are fit for each of the m candidate survival models.
After minimizing equation (6), the stacked estimate of the conditional
survival function for treatment a is
Sˆ(a)(t|x) =
m∑
k=1
αˆ
(a)
k Sˆ
(a)
k (t|x), (7)
where Sˆ
(a)
k (t|x) is the kth survival model estimated with all observations on
treatment a. The treatment-specific restricted means and the restricted mean
treatment effects are then estimated with equations (3) and (4), respectively.
We estimate confidence intervals with the non-parametric bootstrap (Efron
and Tibshirani, 1993). In particular, we randomly sample with replacement
n of the observed {yi, δi, ai,xi}; this is called the bth bootstrap data set.
The bth bootstrapped estimate of the kth treatment-specific conditional sur-
vival function is defined as Sˆ
(a)
k,b (t|x). Since the stacking weights are re-
estimated for each bootstrap, the final estimate of the conditional survival
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function for treatment a with data from the bth bootstrap is Sˆ
(a)
b (t|x) =∑m
k=1 αˆ
(a)
k,bSˆ
(a)
k,b (t|x). The bth bootstrap estimates for the treatment-specific
restricted means and restricted mean treatment effect are calculated as be-
fore [see equations (3) and (4)]. The confidence interval of the restricted
mean treatment effect (γˆ(τ)) can then be estimated by the 2.5th and 97.5th
percentiles of the bootstrap distribution.
Remark 1. The Brier Score measures agreement at only one particular
time. As such, the set of values (i.e., t1, ..., ts) over which the Brier Score is
minimized [see equation (6)] has implications for performance. In particular,
care should be taken to avoid picking only very small, or very large values.
Wey et al. (2013) recommend at least nine evenly spaced quantiles of the
observed event distribution to ensure good estimation of the conditional sur-
vival function. The effect of the set of time points over which the Brier Score
is minimized is investigated in the Supporting Information.
Remark 2. Wey et al. (2013) show that, given the stack contains a uni-
formly consistent estimator of the conditional survival function, the stacked
estimator is uniformly consistent for the underlying conditional survival func-
tion. Therefore, when at least one model within the set of candidate survival
models is correctly specified, γˆ(τ) is consistent for the true restricted mean
treatment effect by the dominated convergence theorem (Ferguson, 1996).
The proposed estimator is, therefore, consistent in a wider range of scenarios
than previous methods that assume a proportional hazards model to estimate
the conditional survival distribution.
4 Simulation Study
4.1 Set-up
The simulation study evaluates the finite sample performance for estimating
the causal restricted mean treatment effect with stacked survival models.
We consider four different data-generating scenarios, indexed by b, for the
covariate-adjusted survival distribution of the potential outcomes. When b =
1, 2 then T ab ∼ Exp[exp{λab}], where E{T ab } = 1/ exp{λab}; when b = 3, 4 then
T ab ∼ Gamma[scale = exp{λab}, shape = 2.5], where E{T ab } = 2.5 · exp{λab}.
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The covariate effects for the control group (i.e., λ0b) are
λ01 = −4.50− 0.125 · {x1 + x2 + x3 + x4}
λ02 = −0.70− 1.000 · {Φ(4× x1) + Φ(4× x2) + Φ(4× x3) + Φ(4× x4)}
λ03 = 3.50− 0.125 · {x1 + x2 + x3 + x4}
λ04 = 4.50− 0.500 · {Φ(4× x1) + Φ(4× x2) + Φ(4× x3) + Φ(4× x4)},
where Φ(·) is the cumulative distribution function of a standard normal distri-
bution (i.e., the non-linear effect is a ‘smooth step function’). The covariate
effects for the treatment group (i.e., λ
(1)
b ) are
λ11 = −3.50− 0.125 · {x1 + x2 + x3 + x4}
λ12 = −1.70− 1.000 · {Φ(4× x1) + Φ(4× x2) + Φ(4× x3) + Φ(4× x4)}
λ13 = 3.00− 0.125 · {x1 + x2 + x3 + x4}
λ14 = 4.00− 0.500 · {Φ(4× x1) + Φ(4× x2) + Φ(4× x3) + Φ(4× x4)}.
The censoring distributions are defined similarly with λ
(a)
b replaced by γ
(a)
b ,
and are designed to achieve a marginal censoring rate of approximately 30%.
The censoring distributions for the control group (i.e., γ(0)) are
γ01 = −4.895− 0.0625 · {x1 + x2 + x3 + x4}
γ02 = −3.680− 0.5000 · {Φ(4× x1) + Φ(4× x2) + Φ(4× x3) + Φ(4× x4)}
γ03 = 3.780− 0.0625 · {x1 + x2 + x3 + x4}
γ04 = 4.765− 0.5000 · {Φ(4× x1) + Φ(4× x2) + Φ(4× x3) + Φ(4× x4)},
while the censoring distributions for the treatment group (i.e., γ(1)) are
γ11 = −5.395− 0.0625 · {x1 + x2 + x3 + x4}
γ12 = −4.680− 0.5000 · {Φ(4× x1) + Φ(4× x2) + Φ(4× x3) + Φ(4× x4)}
γ13 = 3.280− 0.0625 · {x1 + x2 + x3 + x4}
γ14 = 4.265− 0.5000 · {Φ(4× x1) + Φ(4× x2) + Φ(4× x3) + Φ(4× x4)}.
For brevity, we refer to scenarios 1 and 2 as, respectively, the linear and
non-linear exponential scenarios, and scenarios 3 and 4 as, respectively, the
linear and non-linear gamma scenarios.
The covariate distribution is a four-dimensional multivariate normal with
mean zero, unit variances, and a positive AR(1) correlation structure (ρ =
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0.4). To mimic observational studies with confounding, the treatment as-
signment depends on the covariate distribution. In particular, the probabil-
ity of receiving treatment, i.e., P (ai = 1|x) = pi, is defined by logit(pi) =
0.5× (x1 + x2 + x3 + x4).
Each simulation scenario evaluates performance when τ = 20 and τ = 50
with 1, 000 replications and a sample size of 300. The bootstrap distributions
are estimated with 300 bootstrap replicates. All simulations were run in R
version 3.0.0 (R Development Core Team, 2013). The stacking weights are
estimated by minimizing the Brier Score over nine equally spaced quantiles
of the observed events with the constrained minimization problem solved by
the alabama package (Varadhan, 2012).
We consider a mixture of parametric, semi-parametric and non-parametric
candidate survival models. The parametric models are the Weibull model
and log-Normal model with only linear main effects. Both models are spe-
cial cases of an accelerated failure time model, while the Weibull is also a
special case of a proportional hazards model. The semi-parametric models
are two versions of the Cox model. The first Cox model has only linear
main effects, while the second Cox model uses penalized splines for main ef-
fects with the roughness penalty set to 0.5. The survival package estimates
both the parametric and semi-parametric models (Therneau, 2013). The
non-parametric estimator in the set of candidate survival models is random
survival forests (RSF), which is estimated with the randomSurvivalForest
package (Ishwaran et al., 2008) with 1, 000 trees grown. We use the default
tuning parameters of the randomSurvivalForest package for RSF.
We consider two different versions of stacked survival models. The first
version excludes random survival forests (RSF) from the set of candidate
survival models, while the second includes RSF. In particular,
1. The ‘Stacked’ estimator only includes the two parametric and two semi-
parametric survival models in the set of candidate survival models.
2. The ‘Stacked (with RSF)’ estimator includes the two parametric mod-
els, two semi-parametric models, and one non-parametric model with
default tuning parameters.
There are two significant motivations for investigating two different versions
of the stacked estimator. The first motivation is the potential reduction
of computational demands. In particular, random survival forests (RSF)
are computationally expensive, which is significantly compounded by the
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non-parametric bootstrap used to estimate confidence intervals. We can
save substantial computational time if the stacked estimator without RSF
performs as well, or better, than the stacked estimators with RSF. The second
motivation is that sample size of 300 is potentially too small for a non-
parametric estimator, such as RSF, to perform well enough to contribute to
a better stacked estimator.
Each restricted mean estimator in this simulation study uses the “regres-
sion” approach described in Section 2.1. The different methods of estimating
the restricted mean differ in their approach to estimating the treatment-
specific conditional survival functions in equation (3). The two versions of
the stacked estimator are compared to a Cox proportional hazards model
with linear main effects (referred to as the ‘Cox estimator’), and a Cox pro-
portional hazards model with penalized splines (referred to as the ‘Splines
estimator’). The Cox estimator was proposed by Chen and Tsiatis (2001),
while the Splines estimator is a straightforward extension of the Cox esti-
mator that should be more robust in a variety of situations. Note that each
stacked estimator includes both the Cox and Splines estimators in the set of
candidate survival models.
The methods are compared on the basis of percent relative bias, i.e.,
100 × [Eδˆ(τ) − δ(τ)]/δ(τ), and the ratio of mean squared error (MSE) to
the Cox estimator, where MSE = E{δˆ(τ) − δ(τ)}2. Confidence interval
performance is assessed with two measures: the ratio of average confidence
interval length (ACL) to the Cox estimator and coverage probability. For
each method, the estimated confidence intervals use the 2.5th and 97.5th
percentiles of the bootstrap distribution with 300 bootstrap replicates. We
also present the ratio of ‘integrated squared survival error’ (ISSE) to the
Cox estimator for each method: ISSEτ{Sˆ(·|x)} = 12 × E
∫ τ
0
{[Sˆ(0)(t|x) −
S(0)(t|x)]2+[Sˆ(1)(t|x)−S(1)(t|x)]2}dt, which corresponds to the average of the
mean-squared error of the treatment-specific conditional survival functions
presented in Section 2.2. All expectations are approximated by averaging
across the 1, 000 replications.
In the exponential scenario with linear covariate effects, the correctly
specified Cox estimator should perform well, while the Splines estimator -
despite being correctly specified - should be slightly less efficient due to in-
creased flexibility. In contrast, for the exponential scenario with non-linear
covariate effects, the Cox estimator should perform poorly due to model
misspecification, while the Splines estimator remains correctly specified and
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should perform relatively well. Despite including both the Cox estimator
and the Splines estimator, both stacked estimators will likely perform rela-
tively worse in both exponential scenarios due to the increased flexibility of
additional models in the stack.
Each parametric and semi-parametric model is misspecified in both gamma
scenarios. However, the parametric models in the stacked estimators closely
approximate the truth in the linear scenario (e.g., same mean function). As
such, in the linear gamma scenario, the stacked estimators should perform
better than both the Cox and Splines estimator due to approximately correct
parametric models. The non-linear gamma scenario assesses the robustness
of each estimator since none of the parametric and semi-parametric models
are correctly specified or closely approximate the underlying mean function.
However, the stacked estimators should perform better than the Cox and
Splines estimators due to the increased flexibility of additional models in the
set of candidate models. This is also an opportunity for the stacked estimator
with random survival forests (RSF) to perform well relative to the Stacked
estimator without RSF.
4.2 Results
Across the different scenarios, the Stacked estimator (without RSF) possesses
as good, or better, bias and MSE than the Stacked estimator with RSF.
The Stacked estimator with RSF also, at times, does not achieve nominal
coverage at this modest sample size. In addition, the Stacked estimator with
RSF actually performs slightly worse than the Stacked estimator (without
RSF) in the non-linear gamma scenario; an advantageous scenario for random
survival forests (RSF). Due to the similar, or better, performance, we only
compare the Cox and Splines estimators to the Stacked estimator (without
RSF) for the rest of this section.
For the exponential scenarios (Table 1), the Stacked estimator possesses
similar, or slightly more, bias than the Cox estimator when the covariate
effects are linear, and the Stacked estimator has similar, or more, bias than
the Splines estimator for both linear and non-linear covariate effect scenarios.
These results are expected as the Cox and Splines estimators are correctly
specified in, respectively, the linear and non-linear exponential scenarios. In
the exponential scenario with non-linear covariate effects, the Stacked es-
timator has approximately ∼ 4% lower relative bias than the misspecified
Cox estimator. In the linear scenario, the Stacked estimator has similar,
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or slightly larger, MSE than the Cox estimator but, in the non-linear sce-
nario, the Stacked estimator has approximately 20% lower MSE than the Cox
estimator. In addition, the Stacked estimator possesses approximately 10%
lower MSE than the Splines estimator in both exponential scenarios. Finally,
the Stacked estimator possesses approximately 5% narrower confidence in-
tervals than the Splines estimator in both scenarios including, surprisingly,
the non-linear scenario. The Stacked estimator is therefore competitive in
the exponential scenarios with linear effects and more efficient than both the
Cox and Splines estimators in the non-linear exponential scenario.
For both gamma scenarios (Table 2), the Stacked estimator possesses
5%−12% less relative bias than the Cox estimator and 1%−6% less relative
bias than the Splines estimator. In addition, the Stacked estimator possesses
8%−20% lower MSE than the Cox estimator and 20%−30% lower MSE than
the Splines estimator. The Cox estimator surprisingly possesses lower MSE
than the Splines estimator and as good, or better, ACL than the Stacked
estimator in almost every gamma scenario. However, aside from ACL, the
Stacked estimator performs better than both the Cox and Splines estimators
under non-proportional hazards.
Wey et al. (2013) motivated stacking with the goal of balancing, for a
given sample size, the low variance of (potentially misspecified) parametric
models with robust (but potentially inefficient) semi-parametric and non-
parametric models. This effect is illustrated in the simulation study even
when the random survival forests (i.e., the non-parametric estimator) are
excluded from the set of candidate survival models. For example, in the linear
exponential scenario, the Stacked estimator possesses as good, or better,
MSE than the correctly specified Cox and Splines estimators. This is likely
due to the inclusion of a correctly specified parametric Weibull model. Yet,
even the Weibull model is misspecified in the non-linear gamma scenario,
the Stacked estimator still performs better than both the Cox and Splines
estimators despite the lack of either a correctly specified parametric model or
a non-parametric estimator. This ability to adaptively find a good balance
between the low variance of (potentially misspecified) parametric models with
the more robust, but still potentially misspecified, semi-parametric models
(e.g., a Cox model with penalized splines) is the most appealing aspect of
stacked survival models.
Section 2.2 argues that performance of the treatment-specific conditional
survival functions will be more tightly associated with MSE, rather than bias,
of the restricted mean treatment effect. Figure 1 provides an illustration of
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this point from the simulation study. In particular, the Pearson correlation of
the ISSE with the MSE of the restricted mean treatment effect is 0.81, while
the correlation of the ISSE with the bias of the restricted mean treatment
effect is 0.68. As illustrated in the Supporting Information, the correlation at
a larger sample size increases for the MSE, while correlation slightly decreases
for the bias.
Remark 3. The Supporting Information contains several additional investi-
gations into the simulation study: a larger sample size, the difference between
the bootstrap standard error and Monte Carlo standard error, different ap-
proaches to confidence interval estimation, and the choice of time points over
which the stacking weights are determined.
5 Effect of Center Volume in Lung Trans-
plantation
We applied the proposed estimator to data from an observational registry
of post-lung transplant survival to estimate the effect of large center volume
on graft survival (i.e., time to death or retransplantation). In particular,
we want to estimate the difference in the restricted mean of post-transplant
survival between high volume centers (defined as > 100 lung transplants
over the past two years (Tsuang et al., 2013)) and low volume centers (de-
fined as ≤ 100 lung transplants over the past two years). However, previous
research has demonstrated that the relationship between transplant type,
which is an important confounder, and the post-transplant hazard is likely
non-proportional (Thabut et al., 2009). Therefore, this example represents a
setting for estimating restricted mean treatment effects with stacked survival
models instead of the Cox proportional hazards model.
The United Network for Organ Sharing (UNOS) collects patient informa-
tion, donor information and survival status of every solid organ transplant
performed in the United States. This analysis only includes lung transplants
performed between January 1, 2008 and December 31, 2011 in adult recipi-
ents receiving their first lung-only transplantation. We adjust for potential
confounding from several patient related covariates including gender, age,
lung allocation score, native disease grouping (obstructive, vascular, cystic
and restrictive), distance walked in six minutes, ventilator use, level of oxy-
gen use, and type of transplant (single versus bilateral lung transplant). We
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also adjust for several donor related covariates: age over 55 years, African
American race, smoking history greater than 20 pack years, and height dif-
ference between donor and recipient. The event of interest is time to death
or retransplantation. A total of 5, 499 transplanted patients were included
in this analysis. Approximately 76% of the survival times were censored.
Similar to Stacked estimator (without random survival forests) in Section
4, the stacked survival model includes two versions of the Cox model, a
Weibull model, and a log-Normal model. The Weibull, log-Normal, and the
first Cox model fit linear main effects to all continuous covariates except the
height difference between donor and recipient, which is fit with a quadratic
main effect. The second Cox model fits penalized splines to each continuous
covariate. The 95% confidence intervals are estimated with 2.5th and 97.5th
quantiles of the bootstrap distribution with 1000 bootstrap replications.
Figure 2 gives the estimated causal restricted mean treatment effect for
high volume versus low volume centers from τ = 0.5 years to τ = 4 years
based on the Stacked estimator and the Cox estimator. Both the Stacked and
Cox estimators estimate a restricted mean difference between large and small
volume centers greater than zero over the range of follow-up, which indicates
better post-transplant survival for high volume centers. The Stacked estimate
is approximately 30 − 60% larger than the Cox estimate from 0.5 years to
1 years, while at 4 years the Stacked estimate is approximately 5% smaller
than the Cox estimate. In addition, the confidence intervals for the Stacked
estimator do not include zero up to about 3 years, while the confidence
intervals for the Cox estimator contain zero until about 1.5 years and becomes
non-significant only from 2.5 to 3.5 years. As illustrated in the simulations,
the difference in significance between the two estimators may be a function
of the consistently lower MSE of the Stacked estimate in non-proportional
hazards scenarios.
Weiss et al. (2009) were specifically interested in the mortality risk for
center volume at one year. Since earlier survival is indicative of peri-operative
and early post-operative mortality (which is relatively high for lung trans-
plantation), the one-year restricted mean survival is a clinically important
outcome. The Stacked estimator suggests a 30% larger difference than the
Cox estimator in the causal restricted mean survival over one year. In ad-
dition, the confidence interval for the Cox estimate includes zero, while that
the Stacked estimator does not.
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6 Concluding Remarks
We frame the estimation of causal restricted mean treatment effects as a
problem of estimating the conditional survival function. In most application
areas, there is little information to suggest a priori an appropriate distribu-
tional assumption for the survival time or functional form for the covariates.
This motivates flexibly estimating restricted mean treatment effects for obser-
vational studies with stacked survival models. In particular, we demonstrate
that stacked survival models successfully estimates an optimal combination
of candidate survival models that performs well at a given sample size.
Restricted mean survival is traditionally estimated by first estimating the
conditional survival distribution with a Cox proportional hazards model, yet
the simulation study illustrates that there is little cost to considering the
more flexible stacked survival models given that they achieve similar mean
squared error (MSE) under proportional hazards. When the proportional
hazards assumption is violated, stacked survival models can substantially
reduce the bias and MSE of the causal restricted mean treatment effect.
In addition, the stacked estimator is consistent in a wider range of situa-
tions compared than current approaches that assume a proportional hazards
model. We also demonstrated that the Stacked estimator identifies a clini-
cally meaningful difference in lung transplantation between high-volume and
low-volume centers for the one year restricted mean, while the proportional
hazards estimator fails detect the difference.
We considered two different approaches to stacked survival models: one
estimator (the ‘Stacked’ estimator) excluded the non-parametric random sur-
vival forests (RSF) from the set of candidate models, and the other estimator
included RSF in the set of candidate models. We found that the Stacked esti-
mator (without RSF) performed as good, or better, and was computationally
faster than the stacked estimator with RSF; these relationships held even
when the sample size was increased to n = 900 (see the Supporting Informa-
tion). Thus, the Stacked estimator without RSF was a reasonable choice for
estimating restricted means with stacked survival models in the simulation
scenarios considered here. However, different scenarios may exhibit meaning-
ful differences in performance when RSF or other non-parametric estimators
are included in the set of candidate survival models. This point illustrates
that the appropriate selection of candidate survival models remains a signif-
icant area of future research for stacked survival models.
There are two main approaches to estimating the causal restricted mean
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treatment effect: the “regression approach” pursued in this paper and an
approach based on inverse-probability weighting (IPW) for treatment assign-
ment and censoring (Schaubel and Wei, 2011; Zhang and Schaubel, 2012).
The IPW approach requires forming models for the censoring and treatment
distributions. The “regression” approach is a more efficient estimator of the
restricted mean difference when the conditional survival model has been cor-
rectly specified. However, the IPW approach is sometimes preferred because
standard methods that estimate the conditional survival distribution may
be overly restrictive (e.g., the Cox proportional hazards model). The flexi-
bility of stacked survival models may mitigate some of the concerns of the
“regression” approach.
Statisticians regularly want to form linear contrasts of the restricted mean
survival. A common approach to restricted mean regression uses pseudo-
observations from the leave-one-out jackknife of the Kaplan-Meier restricted
mean estimator as the outcome variable in a generalized linear model (An-
dersen et al., 2003, 2004). The potential benefit for estimating pseudo-
observations with stacked survival models is not clear. However, an alterna-
tive to pseudo-values is the model-free contrast approach proposed by Rudser
et al. (2012), which would likely benefit from stacked survival models. The
investigation into these areas is a future research interest.
There has been recent research on using model averaging to account for
uncertainty in the confounders of the treatment-outcome relationship (Wang
et al., 2012; Cefalu et al., 2013). However, previous work has assumed that
the structure of the relationship between the covariates and outcome was
known (e.g., linear relationship between covariates and log-hazard) although,
in practice, there is usually little evidence to support a priori assumptions on
the survival outcomes and functional form of the covariate. We demonstrate
that principally averaging different model structures can lead to substantially
better performance in the estimation of the causal restricted mean treatment
effect. Thus, an interesting avenue for future research would consider the se-
lection of covariates based on both the outcome and treatment models, while
also considering different distributional assumptions and functional forms for
the outcome model.
A conditional survival function is required by many methods besides re-
stricted mean treatment effects: for example, censored quantile regression
(Wey et al., 2014), time-dependent ROC curves (Zheng and Heagerty, 2004),
inverse probability-of-censoring weighted estimators (Fine and Gray, 1999),
model-free contrast approaches (Rudser et al., 2012), and dynamic treatment
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regime methods (Zhao et al., 2011). Similar to restricted mean treatment ef-
fect estimation, all of these methods have traditionally used a Cox model or
a non-parametric method to estimate the conditional survival function. The
success of stacked survival models for restricted mean treatment effect esti-
mation illustrates the potential improvement for a wide spectrum of survival
analysis methods.
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Figure 1: An investigation into the relationship between restricted mean
treatment effect performance and the quality of the conditional survival func-
tion estimation, which is measured by integrated squared survival error, or
ISSE = EEx{
∫ τ
0
[Sˆ(t|x)− S(t|x)]2dt}.
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Table 1: Simulation results for the exponential distributed scenarios: N =
300, NSIM = 1000, and a marginal censoring of 30%. The confidence inter-
vals are estimated using the 2.5th and 97.5th quantiles of the non-parametric
bootstrap distribution with 300 bootstrap replicates. ‘Percent Relative Bias’
is the ratio of the bias and true restricted mean difference. ‘MSE Ratio’ is
the ratio of MSE relative to the Cox estimator. ‘ACL Ratio’ is the ratio of
average confidence interval lengths relative to the Cox estimator. ‘Cov’ is
the coverage probability for the confidence interval. ‘ISSE Ratio’ is the ratio
of integrated squared survival error, which corresponds to the mean-squared
of the conditional survival function, relative to the Cox estimator. The γ(20)
and γ(50) are the true restricted mean treatment effects for τ = 20 and
τ = 50, respectively.
Percent
Estimator Relative Bias MSE Ratio ACL Ratio Cov. ISSE Ratio
Linear
γ(20) = −2.965
Cox 1% 1.00 1.00 0.95 1.00
Splines -2% 1.17 1.12 0.96 4.03
Stacked -1% 1.06 1.05 0.96 1.19
Stacked (with RSF) -1% 1.04 0.96 0.93 1.32
Non-Linear
γ(20) = 2.690
Cox 10% 1.00 1.00 0.94 1.00
Splines 3% 0.86 1.04 0.95 1.06
Stacked 5% 0.77 0.98 0.95 0.76
Stacked (with RSF) 6% 0.78 0.86 0.88 0.76
Linear
γ(50) = −12.318
Cox 1% 1.00 1.00 0.95 1.00
Splines 1% 1.16 1.10 0.95 3.60
Stacked 2% 0.99 1.02 0.95 1.11
Stacked (with RSF) 3% 1.01 0.90 0.84 1.20
Non-Linear
γ(50) = 7.929
Cox 10% 1.00 1.00 0.92 1.00
Splines 3% 0.88 1.05 0.95 1.07
Stacked 6% 0.82 0.98 0.94 0.77
Stacked (with RSF) 6% 0.81 0.82 0.92 0.78
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Table 2: Simulation results for the gamma distributed scenarios: N = 300,
NSIM = 1000, and a marginal censoring of 30%. The confidence intervals are
estimated using the 2.5th and 97.5th quantiles of the non-parametric boot-
strap distribution with 300 bootstrap replicates. ‘Percent Relative Bias’ is
the ratio of the bias and true restricted mean difference. ‘MSE Ratio’ is the
ratio of MSE relative to the Cox estimator. ‘ACL Ratio’ is the ratio of av-
erage confidence interval lengths relative to the Cox estimator. ‘Cov’ is the
coverage probability for the confidence interval. ‘ISSE Ratio’ is the ratio of
integrated squared survival error, which corresponds to the mean-squared of
the conditional survival function, relative to the Cox estimator. The γ(20)
and γ(50) are the true restricted mean treatment effects for τ = 20 and
τ = 50, respectively.
Percent
Estimator Relative Bias MSE Ratio ACL Ratio Cov. ISSE Ratio
Linear
γ(20) = −0.753
Cox -13% 1.00 1.00 0.93 1.00
Splines -7% 1.19 1.19 0.95 4.14
Stacked -1% 0.82 1.05 0.95 1.11
Stacked (with RSF) -4% 0.87 1.01 0.89 1.21
Non-Linear
γ(20) = −0.931
Cox -15% 1.00 1.00 0.92 1.00
Splines -6% 1.09 1.15 0.94 1.58
Stacked -3% 0.79 1.04 0.95 0.96
Stacked (with RSF) -7% 0.84 0.99 0.88 0.94
Linear
γ(50) = −6.599
Cox -6% 1.00 1.00 0.93 1.00
Splines -5% 1.23 1.13 0.94 3.64
Stacked -1% 0.92 1.04 0.94 1.08
Stacked (with RSF) -2% 0.94 0.96 0.87 1.16
Non-Linear
γ(50) = −6.407
Cox -13% 1.00 1.00 0.91 1.00
Splines -6% 0.96 1.07 0.94 1.32
Stacked -5% 0.78 1.00 0.94 0.84
Stacked (with RSF) -7% 0.80 0.91 0.86 0.83
25
Figure 2: The estimated difference in restricted means between high volume
centers and low volume centers across a range of τ vaues. The top graph plots
the estimated restricted mean treatment effects for the Cox and Stacked esti-
mators, while the bottom graph standardizes the restricted mean treatment
effect by τ (i.e., γˆ(τ)/τ). The dashed lines are the 95% confidence inter-
val limits. The non-parametric bootstrap estimates the confidence intervals
with the 2.5th and 97.5th quantiles of the bootstrap distribution. The Stacked
estimator does not include random survival forests.
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